This report is the definitive source for orthopedic market intelligence, serving the needs of the orthopedic community through an individual, annual Membership fee of $575.
Special Features of the 2020 Installment Include:
- COVID-19 Impact and Recovery Insights
- Data for Companies with Revenue >$100 Million
- Bonus Excel File of our Raw Numbers
Venture capitalists, financial analysts, device companies, suppliers, consultants, and entrepreneurial-minded surgeons utilize components of this report to set strategy, prioritize actions and move their companies, their initiatives, and their careers-forward.
Users tell us that they use the report to:
- Identify Acquisition Targets and New Customers
- Improve Sales Forecasts
- Bolster Business Plans
- Refine Competitive Analysis
- Expand Your Perspective on Crucial Orthopedic Market Dynamics
- Advance Your Position Inside and Outside Your Company
- Educate New Hires and Veteran Team Members
Within this report, you’ll find:
- Eighty revenue and market share exhibits that are also presented in a standalone Excel file. These include:
- 2019 vs. 2018 revenue estimates for the 43 largest companies (revenue above $199 million) and market share for the top seven
- 2019 vs. 2018 revenue estimates and market share for the top players in each market segment (joint replacement knee, hip, and extremities; spine; trauma; sports medicine; orthobiologics and contract manufacturers)
- 2019 U.S., EMEA, Asia Pacific and Rest of World revenue for the top thirteen companies and others
- Growth rates for the largest players in each segment
- 2017 through 2022 year-over-year projections for the industry overall and each market segment
- A summary of influences that shape the industry and each market segment
- A recap of 2019 strategic activity, including acquisitions, FDA 510(k) clearances, product launches, and funding
- Lists of companies that play in each market segment and the subsegments within which they sell products
- Market drivers and advice regarding the current and critical opportunities and challenges driving the industry. These include:
- The COVID-19 pandemic
- Ambulatory Surgical Centers (ASCs) and outpatient care settings
- New materials
- Mergers & acquisitions in companies and hospitals
- Robotics, computer-assisted surgery and connected ecosystems of products
A Contract Manufacturing chapter that details the sector’s size and market forces. These companies are seen as an extension of device manufacturers’ operations; therefore, they face similar market influences, including consolidation, global expansion, and personnel challenges.
A list of companies that received their first FDA 510(k) clearances and companies that received their first 510(k) clearance in a new market segment, as well as details on the company’s product and headquarter country.
Table of Contents
PREFACENUMBERS AND SEGMENTS
Samples
LOADING...
Companies Mentioned
- Acumed
- Aesculap
- Alphatec/ATEC Spine
- Amplitude
- Anika Therapeutics
- Arthrex
- Arthrosurface
- Autocam Medical
- Avalign
- Bioventus
- CeramTec
- Conformis
- ConMed
- Corin
- Cretex Companies
- CrossRoads Extremity Systems
- DePuy Synthes
- DJO
- Elos Medtech
- EOS imaging
- Episurf Medical
- Evolutis
- Exactech
- Globus Medical
- GS Medical
- HAPPE Spine
- Heraeus
- Implantcast
- Intech
- Integra LifeSciences
- KARL STORZ
- Kyocera
- LifeNet Health
- LimaCorporate
- Mathys
- Medacta
- Medartis
- Medtronic
- MicroPort Orthopedics
- MiRus
- MTF Biologics
- NN Life Sciences
- NuVasive
- Orchid Orthopedic Solutions
- Orthofix Medical
- OrthoPediatrics
- OsteoMed
- RTI Surgical
- SeaSpine
- Seikagaku
- Smith & Nephew
- Spineart
- Stryker
- Tecomet
- ulrich medical
- Viant
- Waldemar Link
- WishBone Medical
- Wright Medical
- Zimmer Biomet
Methodology
LOADING...